Lamitrin

Lamotrigine, the active ingredient in Lamitrin, is an anticonvulsant presented as an oral tablet for oral use. It is employed in the management of epilepsy and bipolar disorder in adults and adolescents, helping to control seizures and stabilize mood effectively.

GNH USA supplies Lamitrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, ensuring timely delivery and regulatory compliance. Our network covers major markets across Europe, Asia, Africa and the Americas.

Lamitrin acts on neuronal excitability and is indicated for the following conditions:

Epilepsy: reduces the frequency of generalized and partial seizures. Bipolar disorder: stabilizes mood and lowers the incidence of manic episodes. Partial seizures: helps control focal seizure activity.

Lamotrine may be associated with a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome - Toxic epidermal necrolysis - Aseptic meningitis

When prescribing Lamitrin, consider the following precautions: - Dose titration: increase gradually to minimize rash risk. - Skin monitoring: watch for any rash or hypersensitivity signs. - Renal impairment: adjust dose as needed. - Concomitant valproate: may increase lamotrigine levels. - Pregnancy: discuss risks with a healthcare provider. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lamitrin can interact with several medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Valproic acid – markedly increases lamotrigine concentrations, raising toxicity risk. - Carbamazepine – reduces lamotrigine levels, potentially diminishing efficacy. - Oral contraceptives – may lower lamotrigine concentrations, increasing seizure breakthrough.

Moderate Interactions (Monitor Closely): - Phenobarbital – decreases lamotrigine exposure. - Phenytoin – reduces lamotrigine plasma levels. - Serotonergic agents – rare potential for serotonin syndrome.